These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2862700)

  • 41. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G
    Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
    [No Abstract]   [Full Text] [Related]  

  • 42. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 43. Cimetidine reduces the risk of rebleeding from duodenal ulcers displaying signs of recent haemorrhage.
    Stiel D; Barnes PR; Ruppin DC; Byth K; Heap TR
    Scand J Gastroenterol; 1984 Sep; 19(6):798-801. PubMed ID: 6393316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW
    Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers.
    Goldfarb JP; Czaja MJ
    Am J Gastroenterol; 1985 Jan; 80(1):5-7. PubMed ID: 3881014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New drugs. H2 receptor antagonists--cimetidine and ranitidine.
    Feely J; Wormsley KG
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):695-7. PubMed ID: 6130817
    [No Abstract]   [Full Text] [Related]  

  • 49. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy and diagnosis of bleeding peptic ulcer].
    Tanabe S; Saigenji K; Yokoyama Y; Mitsuhashi T
    Nihon Naika Gakkai Zasshi; 1995 Jun; 84(6):922-6. PubMed ID: 7658126
    [No Abstract]   [Full Text] [Related]  

  • 51. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cimetidine and ranitidine in duodenal ulcer.
    Langman MJ; Henry DA; Bell GB; Burnham WR; Ogilvy A
    Br Med J; 1980 Aug; 281(6238):473-4. PubMed ID: 6107154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Formation of a gastric bezoar following upper digestive hemorrhage caused by a medically-treated ulcer].
    Gentile F; Tempesti M; Mancini P
    J Radiol; 1984; 65(6-7):475-6. PubMed ID: 6092631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG; de Looze SM; Bender W; Labs R
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.
    Walt RP; Trotman IF; Frost R; Golding PL; Shepherd TH; Rawlings J; Hunt RH; Colin-Jones D; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Apr; 22(4):319-22. PubMed ID: 6113192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylaxis of stress ulcers: antacid titration vs. histamine2-receptor blockade.
    Gonzalez ER; Morkunas AR
    Drug Intell Clin Pharm; 1985 Nov; 19(11):807-11. PubMed ID: 2866078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Histamine H2 receptor antagonists. Pharmacology and clinical applications].
    Mignon M; Gislon J; Bonfils S
    Rev Prat; 1978 Nov; 28(53):4145-6, 4151-2, 4155-8. PubMed ID: 33441
    [No Abstract]   [Full Text] [Related]  

  • 60. Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Hepatogastroenterology; 1981 Aug; 28(4):216-7. PubMed ID: 6115807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.